Skip to main content
Back to Bills
OntarioPassed41st Parliament, 2nd Session

Bill PR65 explained in plain English

St. Pola Drugs Inc. Act, 2017

Ontario legislature bill summary, status, timeline, sponsor, votes, and official sources.

At a glance

Jurisdiction
Ontario Legislature
Legislature / Parliament
Legislative Assembly of Ontario
Session
41st Parliament, 2nd Session
Bill number
Bill PR65
Full title
St. Pola Drugs Inc. Act, 2017
Current status
Passed
Latest event
Royal Assent received
Last updated
Jun 1, 2017

Official Legislative Assembly of Ontario snapshot for 41st Parliament, 2nd Session. Representative vote breakdowns appear when the Assembly publishes an Ayes and Nays page for the bill.

Chamber
Legislative Assembly of Ontario
Current Stage
Royal Assent received
Latest Activity
Jun 1, 2017
Plain-language explanation
In plain English (our explanation)

Our plain-language take, written for civic education.

Source: By PoliticalData.ca

AI-assisted, reviewed before publishing
Short Version

The St. Pola Drugs Inc. Act, 2017, revives the corporation St. Pola Drugs Inc. to its legal status prior to its dissolution.

What It Means

Bill PR65, also known as the St. Pola Drugs Inc. Act, 2017, revives the corporation St. Pola Drugs Inc. The corporation was dissolved on March 17, 2016. The revival restores the corporation to its legal status as if it had not been dissolved, including its property, rights, and liabilities, subject to any rights acquired by others after its dissolution. The Act came into force on the day it received Royal Assent.

What This Bill Does
  • It revives St. Pola Drugs Inc. and restores it to its legal position as if it had not been dissolved.
  • It specifies that the revival is subject to any rights that have been acquired by any person after the corporation's dissolution.
  • It states that the Act comes into force on the day it receives Royal Assent.
Who Is Affected
  • St. Pola Drugs Inc.
  • Ikbal Boazak (shareholder at dissolution)
  • Maher Boazak (director and shareholder at dissolution)
  • The public and any individuals or entities who acquired rights after the dissolution of St. Pola Drugs Inc.
Rights, Duties, Or Obligations
  • The revival of St. Pola Drugs Inc. is subject to any rights acquired by any person after its dissolution.
Important Dates
  • The Act came into force on the day it received Royal Assent, which was June 1, 2017.
  • St. Pola Drugs Inc. was dissolved on March 17, 2016.
Uncertainties Or Limits
  • The extent to which previously acquired rights by third parties might affect the revival of St. Pola Drugs Inc. is not detailed.
  • The specific 'property that was held in the corporation's name' that the applicants wish to deal with is not detailed.
Laws Or Regulations Affected
St. Pola Drugs Inc.
revival

St. Pola Drugs Inc. is revived and restored to its legal position, including all its property, rights, privileges, franchises, liabilities, contracts, disabilities, and debts, as of the date of its dissolution. This is subject to any rights acquired by any person after its dissolution.

Source: Section 1

Commencement of the Act
commencement

The Act comes into force on the day it receives Royal Assent.

Source: Section 2

Generated using AI from official bill text. Not legal advice. It is written by PoliticalData.ca for civic education, automatically checked and spot-reviewed before publishing.

Official text

Process Snapshot

Step 1
First reading
May 10, 2017
Step 2
Second reading
Jun 1, 2017
Step 3
Committee review
May 17, 2017
Step 4
Third reading
Jun 1, 2017
Step 5
Royal assent
Jun 1, 2017

Vote Summary

No published recorded division

This bill does not have a published recorded division in the current official sources, so representative-by-representative vote counts are not shown.

Sponsor
Gila Martow
Sponsor party or district not listed
Jurisdiction
Ontario Legislature

No published representative vote breakdown

The current official sources do not publish a recorded division breakdown for this bill, so there is no representative-by-representative table to show.

Official sources

Status, sponsor, votes, and timeline on this page are drawn from these official legislative sources and public records. Each summary above is attributed to its own source.

How this data is sourced